Science Board to the Food and Drug Administration; Amendment of Notice

---
identifier: "/us/fr/2014-01298"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Science Board to the Food and Drug Administration; Amendment of Notice"
title_number: 0
title_name: "Federal Register"
section_number: "2014-01298"
section_name: "Science Board to the Food and Drug Administration; Amendment of Notice"
positive_law: false
currency: "2014-01-23"
last_updated: "2014-01-23"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2014-01298"
document_type: "notice"
publication_date: "2014-01-23"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "79 FR 3831"
fr_volume: 79
docket_ids:
  - "Docket No. FDA-2014-N-0001"
fr_action: "Notice."
---


#  Science Board to the Food and Drug Administration; Amendment of Notice

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

**SUMMARY:**

The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Science Board to the Food and Drug Administration. This meeting was announced in the *Federal Register* of January 9, 2014 (79 FR 1645). The amendment is being made to reflect a change in the *Date and Time* and the *Agenda* portions of the document. There are no other changes.

**FOR FURTHER INFORMATION CONTACT:**

Martha Monser, Office of the Chief Scientist, Office of the Commissioner, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 4286, Silver Spring, MD 20993, 301-796-4627, *[email protected]* , or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area). Please call the information line for up-to-date information on this meeting.

**SUPPLEMENTARY INFORMATION:**

In the *Federal Register* of January 9, 2014, FDA announced that a meeting of the Science Board to the Food and Drug Administration would be held on February 5, 2014.

1. On page 1645, in the second column, the *Date and Time* portion of the document is changed to read as follows:

*Date and time:* The meeting will be held on February 5, 2014, from approximately 8:30 a.m. until 1 p.m.

2. On page 1645, in the second column, under *Agenda,* in the first paragraph, after the third sentence, the following sentence is added to read as follows:

The Office of Women's Health (OWH) will seek input from the Board on the development of the OWH Research Roadmap.

This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.

Dated: January 17, 2014.

Leslie Kux,

Assistant Commissioner for Policy.